A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer

NCT00218205 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

28

Enrollment

FED

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Epirubicin
DRUG: Estramustine Phosphate
DRUG: Celecoxib

Sponsor

Department of Veterans Affairs, New Jersey

Collaborators

[object Object]